| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 03/21/2002 | US20020034802 Crystals of the alpha 1 beta 1 integrin I-domain and their use |
| 03/21/2002 | DE10044360A1 Verfahren zur Aufreinigung von rekombinanten als unlösliche Aggregate exprimierte Proteinen A process for the purification of recombinant proteins expressed as insoluble aggregates |
| 03/21/2002 | CA2459599A1 Non-natural basic amino acids, their preparation and use |
| 03/21/2002 | CA2422497A1 Transporters and ion channels |
| 03/20/2002 | EP1189063A1 Method for detecting PSA and its molecular forms using thiophilic gel |
| 03/20/2002 | EP1188769A2 High resolution crystal structure of the ribosome and design of protein synthesis inhibitors |
| 03/20/2002 | EP1187914A1 A structured peptide scaffold for displaying turn libraries on phages |
| 03/20/2002 | EP1187848A1 Annexin derivatives with endogenous chelation sites |
| 03/20/2002 | EP1187626A1 Methods for producing 5'-nucleic acid-protein conjugates |
| 03/20/2002 | EP0925110B1 Conjugate useful for binding substances |
| 03/20/2002 | EP0895546A4 Methods of isolating biological target materials using silica magnetic particles |
| 03/20/2002 | EP0610475B1 Nerve-derived transglutaminase enzyme useful for inducing nerve regeneration |
| 03/20/2002 | EP0593501B1 Biocidal proteins |
| 03/20/2002 | EP0418316B1 Platelet-specific chimeric immunoglobulin |
| 03/20/2002 | CN1341122A Covalently bridged insulin dimers |
| 03/20/2002 | CN1341120A 骨刺激因子 Bone stimulator |
| 03/19/2002 | US6359114 Conjugating protein to preferential particles; obtain liquid, mix preferential particle and protein, conjugate, filter liquid, wash retentate, purify conjugated protein |
| 03/19/2002 | US6359113 Using fused ring system containing at least 4 aromatic rings, and group containing at least one carbon atom which is capable of bonding to a group to be protected; synthesis, separation |
| 03/19/2002 | US6358710 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 |
| 03/19/2002 | US6358703 Expression system for factor VIII |
| 03/19/2002 | US6358689 Detection of markers in nascent proteins |
| 03/19/2002 | US6358489 Fluorination of proteins and peptides for F-18 positron emission tomography |
| 03/19/2002 | US6358479 Reaction block assembly for chemical synthesis |
| 03/19/2002 | US6357163 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 03/19/2002 | CA2136330C Technetium-99m labeled peptides for thrombus imaging |
| 03/14/2002 | WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | WO2002020818A1 Enhanced in vitro synthesis of active proteins containing disulfide bonds |
| 03/14/2002 | WO2002020769A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | WO2002020752A2 Cloned cells, embryos, and avians and methods, of producing them |
| 03/14/2002 | WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | WO2002020722A2 Methods and compositions for in vitro targeting |
| 03/14/2002 | WO2002020630A1 Process for the preparation of glycerol-based crosslinked polymeric gels |
| 03/14/2002 | WO2002020564A2 A method for identifying peptide sequences having a specific functionality |
| 03/14/2002 | WO2002020559A1 Method for purifying recombinant proteins expressed as insoluble aggregates |
| 03/14/2002 | WO2002020558A2 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 03/14/2002 | WO2002020557A1 Extended native chemical ligation |
| 03/14/2002 | WO2002020470A1 T-butoxycarbonylaminoethylamine for the synthesis of pna monomer units, amino acid derivatives, intermediates thereof, and processes for productions of them |
| 03/14/2002 | WO2002020150A2 Photocleavable protecting groups |
| 03/14/2002 | WO2002020034A1 'pseudo'-native chemical ligation |
| 03/14/2002 | WO2002020033A1 Polymer-modified synthetic proteins |
| 03/14/2002 | WO2002019963A2 Synthetic erythropoiesis stimulating proteins |
| 03/14/2002 | WO2001085756A3 Site-selective acyl transfer |
| 03/14/2002 | WO2001081367A3 Purification of polypeptides |
| 03/14/2002 | WO2001079268A3 A glycopeptide and preparation thereof |
| 03/14/2002 | WO2001070768A3 Receptor-binding compounds and method for identifying them |
| 03/14/2002 | WO2001066554A3 Solid phase synthesis method and reagent |
| 03/14/2002 | WO2001062774A3 Purified lh |
| 03/14/2002 | WO2001058921A9 Methods and compositions for generating angiostatin |
| 03/14/2002 | WO2001057066A3 Method of stabilizing a hydrophobin-containing solution and a method of coating a surface with a hydrophobin |
| 03/14/2002 | WO2000055353A9 In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system |
| 03/14/2002 | US20020032317 Adsorbing the protein to Protein A immobilized on a solid phase of silica or glass; washing the solid phase with a hydrophobic electrolyte solvent; and recovering the protein from the solid phase. |
| 03/14/2002 | US20020032309 Methods and compositions for controlled polypeptide synthesis |
| 03/14/2002 | US20020032306 Cyclopeptide derivatives |
| 03/14/2002 | US20020032166 Biocompatible cationic detergents and uses therefor |
| 03/14/2002 | US20020032157 Methods of inhibiting ectopic calcification |
| 03/14/2002 | US20020031806 Purified human erythropoietin receptor protein fragment and antibodies derived therefrom |
| 03/14/2002 | US20020030015 Affinity separation method and system comprising an affinity separation media with low porosity and low non-specific binding |
| 03/14/2002 | CA2421732A1 Photocleavable protecting groups |
| 03/14/2002 | CA2421380A1 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | CA2421271A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2421200A1 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | CA2421195A1 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | CA2421191A1 Methods and compositions for in vitro targeting |
| 03/14/2002 | CA2421174A1 Cloned cells, embryos, and avians and methods, of producing them |
| 03/14/2002 | CA2412298A1 Extended native chemical ligation |
| 03/14/2002 | CA2412279A1 "pseudo"-native chemical ligation |
| 03/14/2002 | CA2412278A1 Polymer-modified synthetic proteins |
| 03/14/2002 | CA2412277A1 Synthetic erythropoiesis stimulating proteins |
| 03/13/2002 | EP1185862A2 Method and compositions relating to insulin resistance disorders |
| 03/13/2002 | EP1185708A1 Means for identifying a novel class of genes resistant to the rice yellow mottle virus and the locus of a major gene of resistance to the virus, and their applications |
| 03/13/2002 | EP1185692A1 Monolayer and electrode for detecting a label-bearing target and method of use thereof |
| 03/13/2002 | EP1185624A1 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells |
| 03/13/2002 | EP1185551A1 Method for purification of proteins |
| 03/13/2002 | EP1185550A1 Metal loaded ligand bound membranes for metal ion affinity chromatography |
| 03/13/2002 | EP1185548A2 Method for drying protein crystals |
| 03/13/2002 | EP0839152B1 Combinatorial libraries of labeled biochemical compounds and methods for producing same |
| 03/13/2002 | CN1340162A Methods and kits for sequencing polypeptides |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355726 Multicomponent ugi reaction; antisense agents, antigens; diagnosis; controlling gene expression by polymeric peptide nucleic acids |
| 03/12/2002 | US6355611 Salt form of a conjugate useful in the treatment of prostate cancer |
| 03/12/2002 | US6355432 Collection of plurality of beads which have binding polymers of different target specific sequence attached thereto; said beads being coded with encoding system whereby target specific sequence of polymer attached to beads can be identified |
| 03/07/2002 | WO2002018447A1 Fusion protein containing additional cationic amino acids and improvement of bio-operation by using same |
| 03/07/2002 | WO2002018443A2 A recombinant monoclonal antibody to phosphotyrosine-containing proteins |
| 03/07/2002 | WO2002018441A2 Electroprocessed fibrin-based matrices and tissues |
| 03/07/2002 | WO2002018432A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 03/07/2002 | WO2002018417A1 Nucleophile-stable thioester generating compounds, methods of production and use |
| 03/07/2002 | WO2002018416A1 Method and functional particles for carrying out chemical or biological reactions or syntheses |
| 03/07/2002 | WO2001055174A3 Universal procedure for refolding recombinant proteins |
| 03/07/2002 | WO2001053325A3 Method of affinity purifying proteins using modified bis-arsenical fluorescein |
| 03/07/2002 | WO2001052612A3 Method for isolating proteins or protein and nucleic acid associations, and resulting complexes of particles and proteins |
| 03/07/2002 | WO2001031006A3 Serum amyloid a isoform from colostrum |
| 03/07/2002 | WO2000071571A8 Fap-activated anti-tumor compounds |
| 03/07/2002 | US20020028917 Separation of avian antibodies |
| 03/07/2002 | US20020028914 Chimeric toxins for targeted therapy |
| 03/07/2002 | US20020028912 Polyethylene glycol derivative modifying granulocyte colony stimulating factor activity |
| 03/07/2002 | US20020028783 Method of stimulating prosaposin receptor activity |
| 03/07/2002 | US20020028771 Sulfonylation core antibiotic |
| 03/07/2002 | US20020028769 Method for preparing zinc-oligopeptide easily absorbable by the human body |
| 03/07/2002 | US20020028503 Devices for molecular biological analysis and diagnostics including waveguides |